Benoit Gautier et al., Nature Communications 2021: https://www.nature.com/articles/s41467-021-22593-3.
Was ist die...Weiterlesen
ElisabethRossaertab...Weiterlesen
Juliette Bacquet et al., in: BMJ Open Vol 8 (2018) issue 10, https://bmjopen.bmj.com/content/8/10/e021632
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats
Prukop et al., 2020 :...Weiterlesen
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
Prukop et al., 2019 :...Weiterlesen
